Summary
Definition
History and exam
Key diagnostic factors
- acanthosis nigricans
- polyuria
- polydipsia
- nocturia
Other diagnostic factors
- hypertension
- yeast infections
- skin infections
- urinary tract infections
- fatigue
- blurred vision
- weight loss
Risk factors
- obesity
- genetic predisposition/family history
- African-American, Hispanic, American-Indian, and Asian or Pacific Islander
- puberty
- female sex
- small for gestational age
- rapid growth in infancy
- diabetic in-utero environment
- bottle feeding
- high protein intake in infancy
- polycystic ovaries
- intramyocellular lipid content
- fat deposition in the liver
Diagnostic tests
1st tests to order
- urine dipstick
- random plasma glucose
- fasting plasma glucose
- HbA1c
- autoantibodies to insulin, islet cells, islet antigens, glutamic acid decarboxylase, and zinc transporter 8
Tests to consider
- 2-hour plasma glucose
- random C-peptide
Treatment algorithm
ketoacidosis or hyperosmolar hyperglycemic nonketotic syndrome
HbA1c <8.5%: no acidosis or ketosis
HbA1c ≥8.5%: no acidosis with or without ketosis
Contributors
Authors
Jennifer Miller, MD
Professor
Department of Pediatrics
University of Florida
Gainesville
FL
Disclosures
JM declares that she has received research funding from Soleno Therapeutics, Harmony Biosciences, Tryp Therapeutics, and Rhythm Pharmaceuticals. JM is an author of a reference cited in this topic.
Chelsea Zimmerman, MD
Clinical Physician
Pediatric Endocrinology
Endocrinology and Metabolism of East Alabama
Opelika
AL
Disclosures
CZ declares that she has no competing interests.
Acknowledgements
Dr Jennifer Miller and Dr Chelsea Zimmerman would like to gratefully acknowledge Dr Arlan Rosenbloom and Dr Paul Hiers, previous contributors to this topic.
Disclosures
AR is an author of a number of references cited in this topic. Unfortunately, we have since been made aware that AR is deceased. PH declares that he has no competing interests.
Peer reviewers
Julian P. Hamilton-Shield, MB, ChB, MD(Bristol), MRCP, FRCPCH, FRCPCH
Professor
Diabetes and Metabolic Endocrinology
School of Clinical Sciences
University of Bristol
UK
Disclosures
In the past, JPHS received speaking honoraria from Sanofi-Aventis, Roche, Abbott, Novo Nordisk, and Nutricia. None of these talks were directly pertinent to the treatment of type 2 diabetes.
Kristen Nadeau, MD
Professor of Pediatrics
University of California
Sacramento
CA
Disclosures
KN declares that she has no competing interests.
Dennis Styne, MD
Professor of Pediatrics
Rumsey Chair of Pediatric Endocrinology
University of California
Sacramento
CA
Disclosures
DS declares that he has no competing interests.
Differentials
- Impaired glucose tolerance
- Type 1 diabetes mellitus (T1DM)
- Monogenic diabetes: maturity-onset diabetes of the young
More DifferentialsGuidelines
- Standards of care in diabetes - 2024
- Type 2 diabetes in children and adolescents
More GuidelinesPatient information
Diabetes type 2: should I take insulin?
Diabetes type 2: what treatments work?
More Patient information- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer